Abdulsamet ERDEN, Umut KALYONCU, Hakan BABAOĞLU, Sibel KADAYIFÇILAR, Murat TORĞUTALP, Ata BAYTAROĞLU

Abnormal retinal microvasculature found in active rheumatoid arthritis: a different perspective of microvascular health

Background/aim: We aimed to assess the association between retinal vascular caliber (RVC) scores and disease activity in rheumatoidarthritis (RA) patients.Materials and methods: Forty-seven RA patients, 32 systemic lupus erythematosus (SLE) patients, and 45 healthy people were enrolled.RA and SLE patients were subdivided into groups according to C-reactive protein (CRP) levels. RA patients were also grouped accordingto Disease Activity Score-28 (DAS-28). Fundus photography was performed for all patients. RVC was summarized as the central retinalartery and vein equivalents (CRAE and CRVE).Results: Mean CRVE for RA patients was 213.3 ± 17.8 µm compared with 209.2 ± 14.1 µm for SLE and 217.5 ± 26.2 µm for the controlgroup (P = 0.17). RVC scores did not differ between the CRP-high and CRP-low groups. As the RA disease activity increased, thewidening of CRVE became more prominent and statistically significant. When the DAS-28 > 5.1 (CRVE, 220.4 (211.8–246.5) µm) groupand DAS-28 ≤ 3.2 (CRVE, 214.4 (172.4–242.3) µm) group were compared, statistical significance was more pronounced (P = 0.03) thanwhen comparing the DAS-28 > 3.2 and DAS-28 ≤ 3.2 groups (P = 0.05).Conclusion: CRVE, which reflects systemic inflammation and possibly increased cardiovascular risk, was significantly increased inactive RA patients. The association between retinal venular widening and disease activity, regardless of CRP, may be a sign that RArelated inflammation may have systemic vascular effects even with normal levels of CRP.

PDF

___

1. WHO. Cardiovascular Diseases (CVDs). Geneva, Switzerland: WHO; 2016.
2. Camici PG, Crea F. Coronary microvascular dysfunction. N Engl J Med 2007; 356: 830-840.
3. Leung DY, Leung M. Significance and assessment of coronary microvascular dysfunction. Heart 2011; 97: 587-595.
4. Gkaliagkousi E, Gavriilaki E, Doumas M, Petidis K, Aslanidis S, Stella D. Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management. J Clin Rheumatol 2012; 18: 422-430.
5. Bergholm R, Leirisalo-Repo M, Vehkavaara S, Mäkimattila S, Taskinen MR, Yki-Järvinen H. Impaired responsiveness to NO in newly diagnosed patients with rheumatoid arthritis. Arterioscler Thromb Vasc Biol 2002; 22: 1637-1641.
6. Pieringer H, Pichler M. Cardiovascular morbidity and mortality in patients with rheumatoid arthritis: vascular alterations and possible clinical implications. QJM-Int J Med 2011; 104: 13-26.
7. Recio-Mayoral A, Mason JC, Kaski JC, Rubens MB, Harari OA, Camici PG. Chronic inflammation and coronary microvascular dysfunction in patients without risk factors for coronary artery disease. Eur Heart J 2009; 30: 1837-1843.
8. Arosio E, Marchi S De, Rigoni A, Prior M, Delva P, Lechi A. Forearm haemodynamics, arterial stiffness and microcirculatory reactivity in rheumatoid arthritis. J Hypertens 2007; 25: 1273- 1278.
9. Wong TY, Knudtson MD, Klein R, Klein BEK, Meuer SM, Hubbard LD. Computer-assisted measurement of retinal vessel diameters in the Beaver Dam Eye Study: methodology, correlation between eyes, and effect of refractive errors. Ophthalmology 2004; 111: 1183-1190.
10. Wong TY, Islam FMA, Klein R, Klein BEK, Cotch MF, Castro C, Sharrett AR, Shahar E. Retinal vascular caliber, cardiovascular risk factors, and inflammation: the Multi-Ethnic Study of Atherosclerosis (MESA). Invest Ophthalmol Vis Sci 2006; 47: 2341-2350.
11. Sun C, Wang JJ, Mackey DA, Wong TY. Retinal vascular caliber: systemic, environmental, and genetic associations. Surv Ophthalmol 2009; 54: 74-95.
12. Ikram MK, de Jong FJ, Vingerling JR, Witteman JC, Hofman A, Breteler MM, de Jong PT. Are retinal arteriolar or venular diameters associated with markers for cardiovascular disorders? The Rotterdam Study. Invest Ophthalmol Vis Sci 2004; 45: 2129- 2134.
13. McGeechan K, Liew G, Macaskill P, Irwig L, Klein R, Klein BE, Wang JJ, Mitchell P, Vingerling JR, Dejong PT et al. Metaanalysis: retinal vessel caliber and risk for coronary heart disease. Ann Intern Med 2009; 151: 404-413.
14. Datta D, Ferrell WR, Sturrock RD, Jadhav ST, Sattar N. Inflammatory suppression rapidly attenuates microvascular dysfunction in rheumatoid arthritis. Atherosclerosis 2007; 192: 391-395.
15. Van Doornum S, Strickland G, Kawasaki R, Xie J, Wicks IP, Hodgson LA, Wong TY. Retinal vascular calibre is altered in patients with rheumatoid arthritis: a biomarker of disease activity and cardiovascular risk? Rheumatology (Oxford) 2011; 50: 939-943.
16. Moi JH, Hodgson LA, Wicks IP, Wong TY, Van Doornum S. Suppression of inflammatory disease activity in rheumatoid arthritis is associated with improvements in retinal microvascular health. Rheumatology (Oxford) 2016; 55: 246-251.
17. Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham CO, Birnbaum NS, Burmester GR, Bykerk VP, Cohen MD et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 2010; 62: 2569-2581.
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725.
19. Weber MA, Schiffrin EL, White WB, Mann S, Lindholm LH, Kenerson JG, Flack JM, Carter BL, Materson BJ, Ram CV et al. Clinical practice guidelines for the management of hypertension in the community. J Clin Hypertens 2014; 16: 14- 26.
20. Stone NJ, Robinson JG, Lichtenstein AH, Bairey Merz CN, Blum CB, Eckel RH, Goldberg AC, Gordon D, Levy D, LloydJones DM et al. 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: A report of the American College of Cardiology/ American Heart Association task force on practice guidelines. Circulation 2014; 129; 1-45.
21. van Gestel AM, Haagsma CJ, van Riel PL. Validation of rheumatoid arthritis improvement criteria that include simplified joint counts. Arthritis Rheum 1998; 41: 1845-1850.
22. Prevoo ML, van’t Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995: 38: 44-48.
23. Fransen J, van Riel PL. The Disease Activity Score and the EULAR response criteria. Rheum Dis Clin North Am 2009; 35: 745-757.
24. Fries JF, Spitz P, Kraines RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum 1980; 23: 137-145.
25. Knudtson MD, Lee KE, Hubbard LD, Wong TY, Klein R, Klein BE. Revised formulas for summarizing retinal vessel diameters. Curr Eye Res 2003; 27: 143-149.
26. Okada M, Wong TY, Kawasaki R, Baharuddin NB, Colville D, Buchanan R, Savige J. Retinal venular calibre is increased in patients with autoimmune rheumatic disease: a case-control study. Curr Eye Res 2013; 38: 685-690.